General
India expects lion’s share of surplus US AstraZeneca vaccines as COVID-19 cases mount
India expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources said as New Delhi battles a devastating surge in infections.
Key points:
-
Indian government sources say they expect India to receive the largest chunk of the US’s surplus vaccine doses
-
COVID-19 cases in India continue to rise, with the eastern state of West Bengal primed to be the country’s next big outbreak
-
India’s High Commission in Canberra responded to a news article in The Australian criticising Prime Minister Narendra Modi, calling it “malicious” and “slanderous”
On Monday, the White House said 10 million doses could be cleared for export “in coming weeks” and the rest…
-
Noosa News23 hours agoTranslink data shows buses are late more often as Queensland approaches one year of 50¢ fares
-
General22 hours agoTesla approves shares worth $US29 billion to Elon Musk
-
General21 hours agoIndia defeats England in fifth Test to tie the series as Chris Woakes bats in a sling
-
Business12 hours agoWhy this beaten-down ASX 200 dividend stock could be set to rebound